We don’t really play in the biotech field that much, but when we come across a company that has been consistently growing revenue and/or is profitable, we dig further. We particularly like companies that offer services to other biotech firms […]
While insiders and related parties skim cream off the top… Chuys Holdings (NASDAQ:CHUY), through its wholly owned subsidiary, Chuy’s Opco, Inc., owns and operates Chuy’s, a full-service restaurant offering a distinct menu of authentic, freshly-prepared Mexican and Tex Mex inspired […]
Navidea Biopharmaceuticals (NAVB) is one of the most attractive short opportunities we have seen in some time. The company resubmitted its long-awaited drug candidate, Lymphoseek, to the FDA on October 31, 2012. Any “emotional” pop in NAVB’s share price that […]
Following the short term trading strategy outlined in an earlier GeoInvesting article, the team initiated several trades this past week sparked by the release of a slew of earnings reports. As always, we may sell any of these positions after […]
By Dune Lawrence Jan. 14 (Bloomberg) — On an April afternoon in 2009, in his home office near Austin, Texas, John Bird was hunched over his computer trying to figure out if a Chinese company some 6,500 miles away was […]
In this video, Zack toured the Weikang Biotech (WKBT) facilities where he witnessed soft capsule processing, as well as a few other aspects of Weikang’s specialties.